Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681081 · ClinicalTrials.gov registry record · NA
Optimizing Chronic Pain Treatment With Enhanced Neuroplastic Responsiveness
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02681081 is a NA study that has completed, run by University of Florida. The registered enrollment target is 26 participants.
The verdict
NCT02681081, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of the study is to identify non-invasive strategies that will optimize the neurobiological environment and improve learning and memory in the treatment of chronic pain. The overall aims of the current proposal are to determine if food restriction and/or glucose administration in conjunction with a relaxation/guided imagery exercise will result in neurophysiological changes and functional improvements compared to the relaxation/guided imagery exercise alone.
Interventions
- OTHER Control
- OTHER Intermittent Fasting
- OTHER Glucose Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-07-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02681081
The ClinicalTrials.gov registry entry for NCT02681081 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT02681081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02681081 about?
NCT02681081 is a clinical study titled "Optimizing Chronic Pain Treatment With Enhanced Neuroplastic Responsiveness". The purpose of the study is to identify non-invasive strategies that will optimize the neurobiological environment and improve learning and memory in the treatment of chronic pain. The overall aims of the current proposal are to determine if food restriction and/or glucose administration in conjunct...
What is the current status of trial NCT02681081?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2016-02. Estimated completion is 2019-07-12.
What interventions are being tested in trial NCT02681081?
The interventions under investigation include: Control (OTHER), Intermittent Fasting (OTHER), Glucose Administration (OTHER).
Who is sponsoring clinical trial NCT02681081?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.